Immunology/Inflammation
Read More about this categoryShow Less
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Research Areas
- 5-Lipoxygenase(17)
- Apoptosis(914)
- Cyclic GMP-AMP Synthase(7)
- TLR(139)
- Papain(1)
- PGDS(1)
- PGE synthase(26)
- SIKs(13)
- IκB/IKK(72)
- AP-1(15)
- KEAP1-Nrf2(65)
- NOD1(1)
- NF-κB(336)
- Interleukin Related(364)
- 15-lipoxygenase(2)
- Others(10)
- Aryl Hydrocarbon Receptor(43)
- CD73(18)
- Complement System(83)
- Galectin(14)
- IFNAR(72)
- NO Synthase(108)
- NOD-like Receptor (NLR)(77)
- STING(125)
- Reactive Oxygen Species(557)
- FKBP(17)
- eNOS(4)
- iNOS(29)
- nNOS(20)
- Glutathione(54)
- Adaptive Immunity(210)
- Allergy(118)
- Arthritis(34)
- Autoimmunity(181)
- Gastric Disease(95)
- Immunosuppressants(38)
- Immunotherapeutics(4)
- Innate Immunity(566)
- Pulmonary Diseases(110)
- Reactive Nitrogen Species(50)
- Specialized Pro-Resolving Mediators(49)
- Reactive Sulfur Species(28)
- BCL6(9)
- CD20(15)
- CD22(2)
- CD28(10)
- PSMA(17)
- FAP(27)
- Nuclear Factor of activated T Cells (NFAT)(4)
- Glycoprotein VI(2)
- Tim3(6)
- Hapten(1)
- Nectin-4(3)
- DOCK(4)
- MHC(15)
- Transmembrane Glycoprotein(56)
- TREM receptor(14)
- Inflammation or Immune System Disease(2)
- Musculoskeletal and Skin Disease(1)
- Fc Receptor (FcR)(16)
- IKZF Family(5)
- C-type Lectin-like Receptors (CTLRs)(13)
- Asialoglycoprotein Receptor (ASGPR)(3)
- Human leukocyte immunoglobulin (Ig)-like receptors (LILR)(2)
- RIG-I-like receptor (RLR)(1)
- VAP-1(1)
Products Related to Immunology/Inflammation(4985)
- GC72012DehydrocrenatidineCAS: 65236-62-6Purity: >98.00%
Dehydrocrenatidine, un alcaloide natural, es un inhibidor específico de JAK.
- GC72018GoniothalaminCAS: 17303-67-2Purity: >98.00%
Goniothalamin (GTN) es estirillactona con propiedades anticancerígenas, antiinflam, inmunosupres.
- GC720664-Methyl-6-phenyl-2H-pyranoneCAS: 4467-30-5
4-Methyl-6-phenyl-2H-pyranone can be used for the synthesis of N-hydroxypyridone derivatives, which can protect astrocytes against hydrogen peroxide-induced toxicity via improved mitochondrial functionality.
- GC72139Peptide5 TFA
Peptide5 TFA, un péptido 43 mimético de conexina, reduce la hinchazón de los animales, astrogliosis, y muerte de la célula neuronal después de lesión de médula espinal.
- GC72183[D-Leu-4]-OB3CAS: 289056-32-2Purity: >99.00%
[D-Leu-4]-OB3 inhila la expresión de genes proinflam, proliferativos y metastásicos y la expresión de pd-l1.
- GC72186WLSEAGPVVTVRALRGTGSWCAS: 771479-86-8Purity: >96.00%
WLSEAGPVVTVRALRGTGSW es un péptido específico de cardiomioci.
- GC72187ErepdekinraCAS: 2641313-47-3Purity: >98.50%
Erepdekinra es un antagonista del receptor de interleucin-17a (IL-17A).
- GC72216(Gly14)-Humanin (human) (acetate)Purity: >98.00%
(Gly14)-Humanin (human) (acetate) es un análogo de la humanina en la que el 14 º aminoácido serina fue reemplazado con glicina (Gly).
- GC72251Tripeptide-32CAS: 1185583-20-3Purity: >99.00%
Tripeptide-32 es un péptido bioactivo con efecto anti-envejecimiento y se ha utilizado como ingrediente cosmé.
- GC72255Tripeptide-41CAS: 1093241-16-7Purity: >99.00%
Tripeptide-41(CG-Lipoxyn) es un péptido biobioque reduce la acumulación de grasa y se ha utilizado como ingrediente cosmé.
- GC72320TemtokibartCAS: 2639874-57-8Purity: >99.00%
Temtokibart es un anticuerpo humaniigg1 − 2 dirigido a IL22RA1.
- GC72324DazukibartCAS: 2639474-65-8Purity: >99.00%
Dazukibart es un anticuerpo IgG1κ humaniderivado del ratón que se dirige a interferón beta 1 (IFNB1).
- GC72326RiliprubartCAS: 2756228-76-7Purity: >99.00%
Riliprubart (SAR445088) es un anticuerpo monoclonal humanianti-c1s que inhic1s activado en la porción proximal del sistema de complemento clásico.
- GC72327StapokibartCAS: 2734715-10-5Purity: >96.00%
Stapokibart (CM310) es un anticuerpo monoclonal humanidirigido a la IL-4Rα y bloquea eficazmente la interacción de las citocinas IL-4 y IL-13 con su subunidad correceptil-4r α.
- GC72340EnokizumabCAS: 909875-08-7Purity: >99.00%
Enokizumab (MEDI-528) es un anticuerpo monoclonal dirigido a la interleucina (IL)-9.
- GC72345TildrakizumabCAS: 1326244-10-3Purity: >95.00%
Tildrakizumab (SCH 900222) es un anticuerpo monoclonal humanianti-il-23 (subunidad P19).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC72012 | Dehydrocrenatidine | 65236-62-6 | >98.00% | |
Dehydrocrenatidine, un alcaloide natural, es un inhibidor específico de JAK. | ||||
| GC72018 | Goniothalamin | 17303-67-2 | >98.00% | |
Goniothalamin (GTN) es estirillactona con propiedades anticancerígenas, antiinflam, inmunosupres. | ||||
| GC72054 | Obovatol | 83864-78-2 | >99.00% | |
Obovatol es un lignan de éter bifenílico aislado de las hojas de Magnolia obovata Thunb. | ||||
| GC72061 | β-Phellandrene | 555-10-2 | >99.50% | |
β-Phellandrene se obtiene de Carum petroselinum. | ||||
| GC72066 | 4-Methyl-6-phenyl-2H-pyranone | 4467-30-5 | - | |
4-Methyl-6-phenyl-2H-pyranone can be used for the synthesis of N-hydroxypyridone derivatives, which can protect astrocytes against hydrogen peroxide-induced toxicity via improved mitochondrial functionality. | ||||
| GC72067 | Pratol | 487-24-1 | - | |
Pratol es un potente inhibidor de NF- − B. | ||||
| GC72081 | Antcin A | 163597-24-8 | - | |
Antcin A es un potente inhibidor del NLRP3 que inhiel ensamby activación del inflammasoma NLRP3. | ||||
| GC72103 | Kp7-6 | 629628-53-1 | >98.00% | |
Kp7-6, un péptido mimético Fas, es un antagonista Fas/FasL. | ||||
| GC72139 | Peptide5 TFA | - | - | |
Peptide5 TFA, un péptido 43 mimético de conexina, reduce la hinchazón de los animales, astrogliosis, y muerte de la célula neuronal después de lesión de médula espinal. | ||||
| GC72183 | [D-Leu-4]-OB3 | 289056-32-2 | >99.00% | |
[D-Leu-4]-OB3 inhila la expresión de genes proinflam, proliferativos y metastásicos y la expresión de pd-l1. | ||||
| GC72186 | WLSEAGPVVTVRALRGTGSW | 771479-86-8 | >96.00% | |
WLSEAGPVVTVRALRGTGSW es un péptido específico de cardiomioci. | ||||
| GC72187 | Erepdekinra | 2641313-47-3 | >98.50% | |
Erepdekinra es un antagonista del receptor de interleucin-17a (IL-17A). | ||||
| GC72216 | (Gly14)-Humanin (human) (acetate) | - | >98.00% | |
(Gly14)-Humanin (human) (acetate) es un análogo de la humanina en la que el 14 º aminoácido serina fue reemplazado con glicina (Gly). | ||||
| GC72251 | Tripeptide-32 | 1185583-20-3 | >99.00% | |
Tripeptide-32 es un péptido bioactivo con efecto anti-envejecimiento y se ha utilizado como ingrediente cosmé. | ||||
| GC72255 | Tripeptide-41 | 1093241-16-7 | >99.00% | |
Tripeptide-41(CG-Lipoxyn) es un péptido biobioque reduce la acumulación de grasa y se ha utilizado como ingrediente cosmé. | ||||
| GC72284 | M-TriDAP | 60230-21-9 | - | |
M-TriDAP (n-acetilmuramill-ala - − -d-glu-meso-diaminopimeácido) es un NOD1/2 agoist y péptido biológico activo. | ||||
| GC72306 | Lib2-1 | 2983116-47-6 | >99.00% | |
Lib2-1, un péptido macrocíclic, es un inhibidor de la interacción IL-17C/IL-17RE. | ||||
| GC72319 | Atrosab | 1365659-05-7 | >96.00% | |
Atrosab es un anticuerpo anti-TNFR1 anti-igg1. | ||||
| GC72320 | Temtokibart | 2639874-57-8 | >99.00% | |
Temtokibart es un anticuerpo humaniigg1 − 2 dirigido a IL22RA1. | ||||
| GC72324 | Dazukibart | 2639474-65-8 | >99.00% | |
Dazukibart es un anticuerpo IgG1κ humaniderivado del ratón que se dirige a interferón beta 1 (IFNB1). | ||||
| GC72326 | Riliprubart | 2756228-76-7 | >99.00% | |
Riliprubart (SAR445088) es un anticuerpo monoclonal humanianti-c1s que inhic1s activado en la porción proximal del sistema de complemento clásico. | ||||
| GC72327 | Stapokibart | 2734715-10-5 | >96.00% | |
Stapokibart (CM310) es un anticuerpo monoclonal humanidirigido a la IL-4Rα y bloquea eficazmente la interacción de las citocinas IL-4 y IL-13 con su subunidad correceptil-4r α. | ||||
| GC72340 | Enokizumab | 909875-08-7 | >99.00% | |
Enokizumab (MEDI-528) es un anticuerpo monoclonal dirigido a la interleucina (IL)-9. | ||||
| GC72345 | Tildrakizumab | 1326244-10-3 | >95.00% | |
Tildrakizumab (SCH 900222) es un anticuerpo monoclonal humanianti-il-23 (subunidad P19). | ||||
